These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38886335)

  • 1. In silico identification and in vitro evaluation of MRPS30-DT lncRNA and MRPS30 gene expression in breast cancer.
    Shirani N; Mahdi-Esferizi R; Eshraghi Samani R; Tahmasebian S; Yaghoobi H
    Cancer Rep (Hoboken); 2024 Jun; 7(6):e2114. PubMed ID: 38886335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRPS30-DT Knockdown Inhibits Breast Cancer Progression by Targeting Jab1/Cops5.
    Wu B; Pan Y; Liu G; Yang T; Jin Y; Zhou F; Wei Y
    Front Oncol; 2019; 9():1170. PubMed ID: 31788446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative Expression of
    Rishehri M; Etemadi T; Pisheh L; Koufigar G; Azadeh M
    Genet Res (Camb); 2022; 2022():6787791. PubMed ID: 36160032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15.
    Liu Y; Cheng T; Du Y; Hu X; Xia W
    BMC Mol Cell Biol; 2020 Sep; 21(1):69. PubMed ID: 32998707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profiles and functional prediction of long non-coding RNAs LINC01133, ZEB1-AS1 and ABHD11-AS1 in the luminal subtype of breast cancer.
    Mehrpour Layeghi S; Arabpour M; Shakoori A; Naghizadeh MM; Mansoori Y; Tavakkoly Bazzaz J; Esmaeili R
    J Transl Med; 2021 Aug; 19(1):364. PubMed ID: 34446052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
    Ma D; Chen C; Wu J; Wang H; Wu D
    Breast Cancer; 2019 Jan; 26(1):74-83. PubMed ID: 29974352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
    Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
    J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential roles of lncRNAs DUXAP8, LINC00963, and FOXD2-AS1 in luminal breast cancer based on expression analysis and bioinformatic approaches.
    Arabpour M; Layeghi SM; Bazzaz JT; Naghizadeh MM; Majidzadeh-A K; Shakoori A
    Hum Cell; 2021 Jul; 34(4):1227-1243. PubMed ID: 34043149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.
    Sun T; Song Y; Yu H; Luo X
    Cancer Biol Ther; 2019; 20(6):760-773. PubMed ID: 30810442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Potential Long Non-Coding RNA Candidates that Contribute to Triple-Negative Breast Cancer in Humans through Computational Approach.
    Rahman MM; Hossain MT; Reza MS; Peng Y; Feng S; Wei Y
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non coding RNA COX10-DT promotes the progression of breast cancer via the COX10-DT/miR-206/BDNF axis.
    Sun J; Li X; Yin J; Chen X; Zhu Z; Wu R; Yu E; Mao Z
    Biochem Biophys Res Commun; 2023 Jan; 639():46-53. PubMed ID: 36463760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of differentially expressed long noncoding RNAs, miRNAs and mRNAs in breast cancer brain metastasis.
    An M; Zang X; Wang J; Kang J; Tan X; Fu B
    Epigenomics; 2021 Jul; 13(14):1113-1128. PubMed ID: 34148372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARA lncRNA, is upregulated in liver and breast tumor tissues.
    Raeisi F; Abolfathi M; Ahmadi-Naji R; Iranparast S; Noshadi E; Akbari A; Mahmoudi E; Khaledi M; Arshi A
    Mol Biol Rep; 2019 Feb; 46(1):77-82. PubMed ID: 30367404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decoding LINC00052 role in breast cancer by bioinformatic and experimental analyses.
    Sanchez-Lopez JM; Juarez-Mancera MA; Bustamante B; Ruiz-Silvestre A; Espinosa M; Mendoza-Almanza G; Ceballos-Cancino G; Melendez-Zajgla J; Maldonado V; Lizarraga F
    RNA Biol; 2024 Jan; 21(1):1-11. PubMed ID: 38832821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel lncRNA PSMG3‑AS1 functions as a miR‑143‑3p sponge to increase the proliferation and migration of breast cancer cells.
    Cui Y; Fan Y; Zhao G; Zhang Q; Bao Y; Cui Y; Ye Z; Chen G; Piao X; Guo F; Wang J; Bai Y; Yu D
    Oncol Rep; 2020 Jan; 43(1):229-239. PubMed ID: 31661146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.
    Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM
    BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
    Front Immunol; 2022; 13():891175. PubMed ID: 35990668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation of lncRNA MEG3 impairs chemosensitivity of breast cancer cells.
    Li H; Wang P; Liu J; Liu W; Wu X; Ding J; Kang J; Li J; Lu J; Pan G
    J Clin Lab Anal; 2020 Sep; 34(9):e23369. PubMed ID: 32618397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis.
    Liang Y; Song X; Li Y; Chen B; Zhao W; Wang L; Zhang H; Liu Y; Han D; Zhang N; Ma T; Wang Y; Ye F; Luo D; Li X; Yang Q
    Mol Cancer; 2020 May; 19(1):85. PubMed ID: 32384893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.